Latest news
Loading news…
YD Bio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Bothell, Washington, United States Founded 2020 11-50 employees For Profit
YD Bio is a biotechnology business that is developing advancements in ophthalmology and DNA methylation-based cancer detection technology.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
2
Monthly Visits
Available in Pro Contacts
0
Ticker
YDES
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- YDES
- Exchange
- NASDAQ
- IPO date
- Aug 29, 2025
- Raised at IPO
- $100M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 13
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 43
- HQ
- Bothell, Washington, United States
- Region
- Greater Seattle Area, West Coast, Western US
- Exit date
- Aug 29, 2025
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- -2.4
- Trend (90d)
- -3.3
- Last leadership hire
- Sep 24, 2025
Acquisitions by YD Bio
Loading columns…
0 of 0Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to YD Bio
Loading news…
FAQs about YD Bio
People who checked this page also checked these
Sectors YD Bio invests & acquires in
Browse the full Acquirezy directory.